Brimrose Tech Launches New Biotech Division
Brimrose Technology Corp. (BTC) is excited to announce the unveiling of a new sector, our Biotechnology Division. This opens a new discipline of business for BTC, one which also brings us a strong presence into the life sciences.

In recent months, BTC has been hiring qualified new staff with strong background in biotech, as well as signing agreements with world-class, cutting-edge, biotech research institutes. We are ready and able to add this to the strong lineup of Brimrose products and advanced materials research.

Throughout Brimrose’s history, a core competency has been our ability to take complex, laboratory R&D and transform it into workable products that can help people. We see this same opportunity in biotechnology, which also will benefit from Brimrose’s R&D and manufacturing capabilities, and our ability to rapidly accelerate R&D into sound, commercial products.

Prior to this full-blown commitment, Brimrose Technology already had been edging into this field through potential spinoff brimRAD, which is focused on next-gen radiation detection. A major market for radiation detection is medical imaging. Likewise, Brimrose acousto-optic components are often used in hospitals and other biotech fields, and a major application for our spectrometers is in testing pharmaceuticals.

We already are introducing new products and are working with global-edge organizations to do more. Please check this website often to review our continued progress in this exciting new area for our company.

Also, please don’t hesitate to contact us if you are interested in our new products, working with us, or otherwise are interested. You can find out more by calling us at 410-472-2600 or contact us with your request.